| (N-ME-D-PHE7)-BRADYKININ |
(N-ME-D-PHE7)-BRADYKININ |
158873-14-4 |
| H-HIS-HIS-GLY-VAL-VAL-GLU-VAL-ASP-ALA-ALA-VAL-THR-PRO-GLU-GLU-ARG-HIS-LEU-SER-LYS-OH |
HIS-HIS-GLY-VAL-VAL-GLU-VAL-ASP-ALA-ALA-VAL-THR-PRO-GLU-GLU-ARG-HIS-LEU-SER-LYS |
158561-91-2 |
| FTASE INHIBITOR III |
H-CYS-VAL-2-NAL-MET-OH |
158022-12-9 |
| H-PRO-HIS-CYS-LYS-ARG-MET-OH |
抗氧化肽A |
159147-88-3 |
| (D-ALA7)-ANGIOTENSIN I/II (1-7) |
(D-ALA7)-ANGIOTENSIN I/II (1-7) |
159432-28-7 |
| (D)-PPA 1 |
H-D-ASN-D-TYR-D-SER-D-LYS-D-PRO-D-THR-D-ASP-D-ARG-D-GLN-D-TYR-D-HIS-D-PHE-OH |
1620813-53-7 |
| HCV CORE PROTEIN (59-68) |
HCV CORE PROTEIN (59-68) |
160187-72-4 |
| CYCLO(-GLY-TYR(PO3H2)-VAL-PRO-MET-LEU) |
CYCLO(-GLY-TYR(PO3H2)-VAL-PRO-MET-LEU) |
158778-21-3 |
| AC-ALA-GLU-TYR-TYR-ASN-LYS-GLN-TYR-LEU-GLU-GLN-THR-ARG-ALA-GLU-LEU-ASP-THR-NH2 |
MHC Class II IA- b Chain (58-75) |
157505-54-9 |
| COAGULATION FACTOR XIIIA (190-230) |
COAGULATION FACTOR XIIIA (190-230) |
158455-48-2 |
| H-PHE-SER-OH |
H-PHE-SER-OH |
16053-39-7 |
| H-GLY-BETA-ALA-NH2 HCL |
H-GLY-ALA-NH2 · HCL |
15855-91-1 |
| RAS INHIBITORY PEPTIDE |
RAS INHIBITORY PEPTIDE |
159088-48-9 |
| COLLAGEN TYPE IV ALPHA3 CHAIN (185-203) |
COLLAGEN TYPE IV Α3 CHAIN (185-203) |
157802-35-2 |
| H-GLN-ASP-VAL-HIS-OH |
PTH (29-32) (HUMAN) |
157876-49-8 |
| PTH (1-31) (HUMAN) |
PTH (1-31) (HUMAN) |
157938-23-3 |
| IFN-γ Antagonist, (Tyr121,Cys(Acm)122)-IFN-γ Receptor (120-141) (human) |
IFN-Γ拮抗剂多肽 |
158040-83-6 |
| H-Ala-Gln-Glu-Glu-Ala-Glu-Ala-Glu-Glu-Arg-Arg-Leu-Gln-Glu-Gln-Glu-Glu-Leu-Glu-Asn-Tyr-Ile-Glu-His-Val-Leu-Leu-Arg-Arg-Pro-OH |
AQEE-30 |
160046-70-8 |
| H-PHE-LEU-TRP-GLY-PRO-ARG-ALA-LEU-VAL-OH |
PHE-LEU-TRP-GLY-PRO-ARG-ALA-LEU-VAL |
160295-81-8 |
| QL9 |
QL9 |
159646-83-0 |
QQ
微信
